Baird Medical Investment Holdings Limited (BDMD)

BDMD Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	37.04	31.46	35.09	29.7	18.12
Revenue Growth (YoY)	17.73%	-10.35%	18.16%	63.92%	48.37%
Cost of Revenue	4.38	4.23	7.05	5.03	2.51
Gross Profit	32.65	27.23	28.04	24.67	15.61
Selling, General & Admin	11.16	11.09	10.55	8.64	4.6
Research & Development	6.17	4.27	3.86	1.54	0.75
Other Operating Expenses	-	-	-	0.31	0.19
Operating Expenses	17.34	15.37	14.41	10.07	5.94
Operating Income	15.32	11.86	13.63	14.6	9.67
Interest Expense	-0.58	-0.29	-0.3	-0.15	-0.16
Interest & Investment Income	0	0	0.01	0	0
Currency Exchange Gain (Loss)	-	-	-	0.05	-
Other Non Operating Income (Expenses)	-0.65	0.78	1.18	-0.98	-3.77
EBT Excluding Unusual Items	14.09	12.36	14.52	13.52	5.74
Other Unusual Items	-	-	-	0.79	3.84
Pretax Income	14.09	12.36	14.52	14.32	9.58
Income Tax Expense	1.49	1.7	1.75	2.53	2.43
Earnings From Continuing Operations	12.6	10.66	12.77	11.78	7.15
Minority Interest in Earnings	-0.14	-0.11	-0.21	-0.1	-0.05
Net Income	12.45	10.55	12.57	11.68	7.1
Net Income to Common	12.45	10.55	12.57	11.68	7.1
Net Income Growth	18.09%	-16.09%	7.60%	64.54%	-
Shares Outstanding (Basic)	26	29	29	1,181	-
Shares Outstanding (Diluted)	26	29	29	1,181	-
Shares Change (YoY)	-12.86%	-	-97.51%	-	-
EPS (Basic)	0.49	0.36	0.43	0.01	-
EPS (Diluted)	0.49	0.36	0.43	0.01	-
EPS Growth	35.91%	-16.09%	4220.03%	-	-
Free Cash Flow	-9.17	-3.66	-5.42	5.92	3.25
Free Cash Flow Per Share	-0.36	-0.12	-0.18	0.01	-
Gross Margin	88.17%	86.56%	79.90%	83.08%	86.14%
Operating Margin	41.35%	37.71%	38.85%	49.16%	53.38%
Profit Margin	33.62%	33.52%	35.82%	39.33%	39.18%
Free Cash Flow Margin	-24.75%	-11.63%	-15.46%	19.95%	17.94%
EBITDA	16.45	12.85	14.49	15.42	10.28
EBITDA Margin	44.43%	40.86%	41.30%	51.91%	56.74%
D&A For EBITDA	1.14	0.99	0.86	0.82	0.61
EBIT	15.32	11.86	13.63	14.6	9.67
EBIT Margin	41.35%	37.71%	38.85%	49.16%	53.38%
Effective Tax Rate	10.57%	13.76%	12.03%	17.69%	25.32%

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q